|
⚲
|
| Keyboard |
| MGC Venture Partners 2018 GP LLC
✚
|
|
|---|---|
| CRD # | 298455 |
| SEC # | 802-114038 |
| CIK # | 0001783291 |
| AUM | |
| Employees | |
| Phone | 615-843-9100 |
| Address | 3835 Cleghorn Avenue Nashville, TN 37215 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | MGC Venture Partners 2018 LP | [2018-08-24] | 48.6 M | 53.9 M |
| Offered $125,000,000 · Filed 2018-07-11 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $100,000 · Remaining $76,426,166 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | MGC Venture Partners QP 2018 LP | [2018-08-24] | 25.8 M | 62.4 M |
| Offered $125,000,000 · Filed 2018-08-24 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $250,000 · Remaining $99,238,438 · Duration One year or less · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Joseph Cook III | Executive Officer | 15 | 3 | |
| Robin Readnour | Executive Officer | 10 | 3 | |
| Byron Smith | Executive Officer | 36 | 2 | |
| Joseph Cook Jr | Executive Officer | 18 | 2 | |
| Steven Singleton | Executive Officer | 3 | 2 | |
| Jason Ferguson | Executive Officer | 3 | 2 | |
| Mgc Venture Partners 2018 GP LLC | Executive Officer | 2 | 1 | |
| Mgc VP 2018 Slp | Executive Officer | 2 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001783291] | |
| 4 | [0001783291] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Castle Biosciences Inc CSTL
Common Stock
|
2020-05-15 | Sell | 13,799 | $36.39 | 502,146 |
|
Castle Biosciences Inc CSTL
Common Stock
|
2020-05-15 | Sell | 8,117 | $37.28 | 302,602 |
|
Castle Biosciences Inc CSTL
Common Stock
|
2020-05-13 | Sell | 1,131 | $36.08 | 40,806 |
|
Castle Biosciences Inc CSTL
Common Stock
|
2020-05-12 | Sell | 4,601 | $37.46 | 172,353 |
|
Castle Biosciences Inc CSTL
Common Stock
|
2020-05-12 | Sell | 5,187 | $36.61 | 189,896 |
|
Castle Biosciences Inc CSTL
Common Stock
|
2019-07-29 | Conversion | 1,336,927 | ||
|
Castle Biosciences Inc CSTL
Series A Preferred Stock · derivative
|
2019-07-29 | Conversion | 19,524 | ||
|
Castle Biosciences Inc CSTL
Convertible Promissory Note · derivative
|
2019-07-29 | Conversion | 1,200,000 | ||
|
Castle Biosciences Inc CSTL
Series D Preferred Stock · derivative
|
2019-07-29 | Conversion | 337,754 | ||
|
Castle Biosciences Inc CSTL
Series F Preferred Stock · derivative
|
2019-07-29 | Conversion | 507,762 | ||
|
Castle Biosciences Inc CSTL
Series E-3 Preferred Stock · derivative
|
2019-07-29 | Conversion | 142,843 | ||
|
Castle Biosciences Inc CSTL
Series E-1 Preferred Stock · derivative
|
2019-07-29 | Conversion | 463,453 | ||
|
Castle Biosciences Inc CSTL
Series E-2 Preferred Stock · derivative
|
2019-07-29 | Conversion | 158,379 | ||
|
Castle Biosciences Inc CSTL
Common Stock
|
2019-07-29 | Buy | 62,500 | $16.00 | 1,000,000 |
|
Castle Biosciences Inc CSTL
Common Stock
|
2019-07-29 | Buy | 134,700 | $16.00 | 2,155,200 |
|
Castle Biosciences Inc CSTL
Common Stock
|
2019-07-29 | Buy | 115,300 | $16.00 | 1,844,800 |
|
Castle Biosciences Inc CSTL
Common Stock
|
2019-07-29 | Conversion | 97,428 | $12.80 | 1,247,078 |